Sponsors & Exhibitors
Commercial opportunities
Choose from a variety of sponsorship and commercial options to raise your profile and position your company as a thought leader in the community.
Download sales pack opens in new tab/window
Reasons why being a sponsor is a brilliant marketing strategy
Highly targeted marketing – reach your community
Brand awareness & recognition – logo and advertisement placement
Access to knowledge – find out about new research being undertaken
Engage with your audience online
Media exposure - benefit from being promoted throughout Elsevier’s marketing process
Enhance credibility – highlight your company’s expertise to a captive audience
Generate new sales & form new partnerships – with registrants, vendors and speakers
Leveraged lead generation - the chance to be recommended to attendees’ connections
To discuss your requirements or to book sponsorship or exhibit space please contact:
Chloe Partridge Conference Sponsorship & Classified Advertising Sales Executive Tel: +44 (0) 1865 843 346 Email: [email protected] opens in new tab/window
Please do not email credit card information under any circumstances
Sponsor
Pharmaron
Pharmaron’s Clinical Pharmacology Center provides full-service early-phase clinical research for investigational products, delivering clinical studies with the best quality, cost, and timelines available in the industry. Our 96-bed facility in Baltimore, US, is a recognised viral and bacterial challenge study site, with an experienced team and facility design providing operational excellence to ensure precision and integrity for all studies. Our expertise in First-In-Human studies in multiple therapeutic areas, especially in infectious disease and vaccines, combined with our full suite of clinical pharmacology services, allows our team to advance drug development programs rapidly. Pharmaron has completed >50 viral/bacterial vaccine or challenge studies in campylobacter, cryptosporidium, cholera, influenza, CMV, streptococcus, staphylococcus, RSV, SARS-CoV-2 and norovirus.
Exhibitors
Idevax
Idevax is a medical device company based in Antwerp, Belgium. The company’s flagship product is VAX-ID, a device allowing for accurate, reliable and user-independent intradermal vaccination, or vaccination in the skin with a high ease of use. VAX-ID is an award-winning, patented device. The device is available for investigational use and CE marking as well as FDA approval is expected by the end of 2024. Key applications of the device include prophylactic and therapeutic vaccine delivery as well as immunotherapy.
JPT Peptide Technologies
We are the Peptide Experts!
For over 20 years, JPT Peptide Technologies has been at the cutting edge of peptide synthesis, pioneering patented technologies in the fields of peptide libraries, pools and microarrays as well as micro-scale synthesis.
Our peptide synthesis service ranges from micro-scale synthesis (10 - 50 nmol) to intermediate peptide synthesis (1 – 100 mg) with high throughput capacities for tens of thousands of peptides per month. Select your peptide format (pool, library, ELISA, microarray, etc.), peptide purity (from crude up to >98%), and optional modifications (phospho, biotin, dyes and labels, (macro)cyclization, conjugation, stable-isotope labeling, etc.).
Our state-of-the-art laboratories are located in Berlin, Germany and JPT operates according to the latest ISO 9001:2015 regulations.
Ovagen
Ovagen is a biotechnology company that has developed a proprietary process of producing the world’s first Germ-Free chicken eggs for use in vaccine manufacture, research & development, and other biopharmaceutical applications. Germ-free eggs transform vaccine production by:
Eliminating bacterial contamination and reducing antimicrobial resistance, a holy grail for vaccines
Increasing the yield of vaccines per egg
Increasing quality, security, and sustainability
Reducing carbon footprint, and
Allowing more efficient and cost-effective production of vaccines therefore improving access by poorer nations.
